Approaches to stepping up and stepping down care in asthmatic patients

Journal of Allergy and Clinical Immunology

Volumn 128, Issue 5, 2011, Pages 915-924

  Thomas, Alex ^a   Lemanske Jr , Robert F ^a   Jackson, Daniel J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Asthma; control; guidelines; severity; step down; step up; step up intermittent; step up long term; step up short term; stepwise

Indexed keywords

BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; MEPOLIZUMAB; OMALIZUMAB; PREDNISONE; SALBUTAMOL; TERBUTALINE; ZAFIRLUKAST;

ASTHMA; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; LOW DRUG DOSE; LUNG FUNCTION; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ANTI-ASTHMATIC AGENTS; ASTHMA; HUMANS;

EID: 80053565899     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.07.014     Document Type: Review

References (47)

1. EPR Expert Panel Report: guidelines for the diagnosis and management of asthma (EPR 1991) 1991 US Department of Health and Human Services; National Institutes of Health; National Heart, Lung, and Blood Institute; National Asthma Education and Prevention Program Bethesda NIH publication no. 91-3642
2. EPR-2 Expert Panel Report 2: guidelines for the diagnosis and management of asthma (EPR-2 1997) 1997 US Department of Health and Human Services; National Institutes of Health; National Heart, Lung, and Blood Institute; National Asthma Education and Prevention Program Bethesda NIH publication no. 97-4051
3. EPR Update 2002 Expert Panel Report: guidelines for the diagnosis and management of asthma. Update on selected topics 2002 (EPR-update 2002) 2003 US Department of Health and Human Services; National Institutes of Health; National Heart, Lung, and Blood Institute; National Asthma Education and Prevention Program Bethesda NIH publication no. 02-5074
4. Global Initiative for Asthma (GINA) Pocket guide for asthma management and prevention 1998 National Institutes of Health, National Heart, Lung, and Blood Institute Bethesda Publication no. 95-3659B
5. EPR-3 Expert Panel Report 3: guidelines for the diagnosis and management of asthma (EPR-3 2007) 2007 US Department of Health and Human Services; National Institutes of Health; National Heart, Lung, and Blood Institute; National Asthma Education and Prevention Program Bethesda NIH publication no. 08-5846
6. R.A. Nathan, C.A. Sorkness, M. Kosinski, M. Schatz, J.T. Li, and P. Marcus Development of the Asthma Control Test: a survey for assessing asthma control J Allergy Clin Immunol 113 2004 59 65 (Pubitemid 38096162)
7. A.H. Liu, R. Zeiger, C. Sorkness, T. Mahr, N. Ostrom, and S. Burgess Development and cross-sectional validation of the Childhood Asthma Control Test J Allergy Clin Immunol 119 2007 817 825 (Pubitemid 46527825)
8. E.F. Juniper, P.M. O'Byrne, G.H. Guyatt, P.J. Ferrie, and D.R. King Development and validation of a questionnaire to measure asthma control Eur Respir J 14 1999 902 907 (Pubitemid 29519356)
9. W.M. Vollmer, L.E. Markson, E. O'Connor, L.L. Sanocki, L. Fitterman, and M. Berger Association of asthma control with health care utilization and quality of life Am J Respir Crit Care Med 160 1999 1647 1652
10. A.L. Fuhlbrigge, S.T. Weiss, K.M. Kuntz, and A.D. Paltiel Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma Pediatrics 118 2006 e347 e355 (Pubitemid 46085375)
11. J.E. Gern, and W.W. Busse Relationship of viral infections to wheezing illnesses and asthma Nat Rev Immunol 2 2002 132 138 (Pubitemid 37323237)
12. T.E. Van Metre Jr. , D.G. Marsh, N.F. Adkinson Jr. , J.E. Fish, A. Kagey-Sobotka, and P.S. Norman Dos of cat (Felis domesticus) allergen 1 (Fel d 1) that induces asthma J Allergy Clin Immunol 78 1986 62 75 (Pubitemid 16099926)
13. J.M. Fitzgerald, L.P. Boulet, and R.M. Follows The CONCEPT trial: a 1-year, multicenter, randomized, double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing (AMD) regimen of formoterol/budesonide in adults with persistent asthma Clin Ther 27 2005 393 406 (Pubitemid 40732647)
14. A. Papi, G.W. Canonica, P. Maestrelli, P. Paggiaro, D. Olivieri, and E. Pozzi Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma N Engl J Med 356 2007 2040 2052 (Pubitemid 46789894)
15. F.D. Martinez, V.M. Chinchilli, W.J. Morgan, S.J. Boehmer, R.F. Lemanske, and D.T. Mauger Use of beclomethasone diproprionate as a rescue treatment for children with mild persistent asthma (TREXA): a randomized, double-blind, placebo-controlled trial Lancet 377 2011 650 657
16. A.P. Greening, P.W. Ind, M. Northfield, and G. Shaw Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group Lancet 344 1994 219 224 (Pubitemid 24229008)
17. A. Woolcock, B. Lundback, N. Ringdal, and L.A. Jacques Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids Am J Respir Crit Care Med 153 1996 1481 1488 (Pubitemid 26141329)
18. R.A. Pauwels, C.G. Lofdahl, D.S. Postma, A.E. Tattersfield, P. O'Byrne, and P.J. Barnes Effect of inhaled formoterol and budesonide on exacerbations of asthma N Engl J Med 337 1997 1405 1411 (Pubitemid 27497887)
19. E.D. Bateman, H.A. Boushey, J. Bousquet, W.W. Busse, T.J. Clark, and R.A. Pauwels Can guideline-defined asthma control be achieved? The gaining optimal asthma control study Am J Respir Crit Care Med 170 2004 836 844 (Pubitemid 39346477)
20. R.F. Lemanske, D.T. Mauger, C.A. Sorkness, D.J. Jackson, S.J. Boehmer, and F.D. Martinez Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids N Engl J Med 362 2010 975 985
21. B.A. Chowdhury, and P.G. Dal The FDA and safe use of long-acting beta-agonists in the treatment of asthma N Engl J Med 362 2010 1169 1171
22. S.P. Peters, S.J. Kunselman, N. Icitovic, W.C. Moore, R. Pascual, and B.T. Ameredes Tiotropium bromide step-up therapy for adults with uncontrolled asthma N Engl J Med 363 2010 1715 1726
23. J.K. Sont, L.N. Willems, E.H. Bel, J.H. Van Krieken, J.P. Vandenbroucke, and P.J. Sterk Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group Am J Respir Crit Care Med 159 1999 1043 1051 (Pubitemid 29202534)
24. R.H. Green, C.E. Brightling, S. McKenna, B. Hargadon, D. Parker, and P. Bradding Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial Lancet 360 2002 1715 1721 (Pubitemid 35447900)
25. A.D. Smith, J.O. Cowan, K.P. Brassett, G.P. Herbison, and D.R. Taylor Use of exhaled nitric oxide measurements to guide treatment in chronic asthma N Engl J Med 352 2005 2163 2173
26. S.J. Szefler, H. Mitchell, C.A. Sorkness, P.J. Gergen, G.T. O'Connor, and W.J. Morgan Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial Lancet 372 2008 1065 1072
27. A.D. Smith, J.O. Cowan, and D.R. Taylor Exhaled nitric oxide levels in asthma: personal best versus reference values J Allergy Clin Immunol 124 2009 714 718
28. D.J. Jackson, C.M. Virnig, R.E. Gangnon, M.D. Evans, K.A. Roberg, and E.L. Anderson Fractional exhaled nitric oxide measurements are most closely associated with allergic sensitization in school-age children J Allergy Clin Immunol 124 2009 949 953
29. M. Humbert, R. Beasley, J. Ayres, R. Slavin, J. Hebert, and J. Bousquet Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE Allergy 60 2005 309 316 (Pubitemid 40293346)
30. W.W. Busse, W.J. Morgan, P.J. Gergen, H.E. Mitchell, J.E. Gern, and A.H. Liu Randomized trial of omalizumab for asthma in inner-city children N Engl J Med 364 2011 1005 1015
31. M.J. Leckie, A. ten Brinke, J. Khan, Z. Diamant, B.J. O'Connor, and C.M. Walls Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response Lancet 356 2000 2144 2148
32. P. Haldar, C.E. Brightling, B. Hargadon, S. Gupta, W. Monteiro, and A. Sousa Mepolizumab and exacerbations of refractory eosinophilic asthma N Engl J Med 360 2009 973 984
33. P. Nair, M.M. Pizzichini, M. Kjarsgaard, M.D. Inman, A. Efthimiadis, and E. Pizzichini Mepolizumab for prednisone-dependent asthma with sputum eosinophilia N Engl J Med 360 2009 985 993
34. J.M. Fitzgerald, A. Becker, M.R. Sears, S. Mink, K. Chung, and J. Lee Doubling the dose of budesonide versus mainteance treatment in asthma exacerbations Thorax 59 2004 550 556 (Pubitemid 38901511)
35. J. Oborne, K. Mortimer, R.B. Hubbard, A.E. Tattersfield, and T.W. Harrison Quadrupling the dose of inhaled corticosteroids to prevent asthma exacerbations Am J Respir Crit Care Med 180 2009 598 602
36. H.A. Boushey, C.A. Sorkness, T.S. King, S.D. Sullivan, J.V. Fahy, and S.C. Lazarus Daily versus as-needed corticosteroids for mild persistent asthma N Engl J Med 352 2005 1519 1528
37. R. Aalbers, V. Backer, T.T. Kava, E.R. Omenaas, T. Sandstrom, and C. Jorup Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma Curr Med Res Opin 20 2004 225 240 (Pubitemid 38197324)
38. P.W. Ind, J. Haughney, D. Price, J.P. Rosen, and J. Kennelly Adjustable and fixed dosing with budesonide/ formoterol via a single inhaler in asthma patients: the ASSURE study Respir Med 98 2004 464 475 (Pubitemid 38578729)
39. B. Stallberg, P. Olsson, L.A. Jorgensen, N. Lindarck, and T. Ekstrom Budesonide/formoterol adjustable maintenance dosing reduces asthma exacerbations versus fixed dosing Int J Clin Pract 57 2003 656 661 (Pubitemid 37428199)
40. L.B. Bacharier, B.R. Phillips, R.S. Zeiger, S.J. Szefler, F.D. Martinez, and R.F. Lemanske Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing J Allergy Clin Immunol 122 2008 1127 1135
41. T.W. Guilbert, W.J. Morgan, M. Krawiec, R.F. Lemanske Jr. , C. Sorkness, and S.J. Szefler The Prevention of Early Asthma in Kids study: design, rationale and methods for the Childhood Asthma Research and Education network Control Clin Trials 25 2004 286 310 (Pubitemid 38626165)
42. P.M. O'Byrne, H. Bisgaard, P.P. Godard, M. Pistolesi, M. Palmqvist, and Y.J. Zhu Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma Am J Respir Crit Care Med 171 2005 129 136 (Pubitemid 40105411)
43. J.M. Kramer Balancing the benefits and risks of inhaled long-acting beta-agonists - the influence of values N Engl J Med 360 2009 1592 1595
44. M.R. Sears Safety of long-acting beta-agonists: are new data really required? Chest 136 2009 604 607
45. E.D. Bateman, L. Jacques, C. Goldfrad, T. Atienza, T. Mihaescu, and M. Duggan Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down J Allergy Clin Immunol 117 2006 563 570 (Pubitemid 43340219)
46. P. Godard, P. Greillier, B. Pigearias, G. Nachbaur, J.L. Desfougeres, and V. Attali Maintaining asthma control in persistent asthma: comparison of three strategies in a 6-month double-blind randomised study Respir Med 102 2008 1124 1131
47. S.M. Koenig, N. Ostrom, D. Pearlman, K. Waitkus-Edwards, S. Yancey, and B.A. Prillaman Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down. " J Asthma 45 2008 681 687